Marianne Hansson

Title: The Innovations of Marianne Hansson

Introduction

Marianne Hansson is a notable inventor based in Bl.ang.sutyagen, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA technologies. Her work has implications for various applications in medicine and microbiology.

Latest Patents

Marianne holds a patent for "Recombinant DNA coding for signal peptide, selective interacting - Tripartite recombinant DNA encoding fusion proteins." This invention describes a recombinant DNA that includes a signal peptide operable in Gram-positive bacteria, an immunogenic polypeptide, and a cell wall spanning and membrane anchoring sequence. The preferred polypeptides for this invention include Staphylococcus protein A and Streptococcus protein G. This patent highlights her innovative approach to expressing fusion proteins on the surface of Gram-positive bacteria.

Career Highlights

Marianne is currently associated with Pierre Fabre Medicament, where she continues to advance her research in biotechnology. Her work has been instrumental in developing new methods for protein expression, which can lead to breakthroughs in therapeutic applications.

Collaborations

Some of her notable coworkers include Stefan Stanghl and Per-ANGke Nygren. Their collaborative efforts have contributed to the success of her projects and the advancement of their shared research goals.

Conclusion

Marianne Hansson's contributions to biotechnology through her innovative patents and collaborative work exemplify the impact of dedicated inventors in the scientific community. Her research continues to pave the way for advancements in medical applications.